|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,140.00 JPY | +1.57% |
|
-0.97% | +2.25% |
| 06-04 | Astellas Pharma Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:10 AM | |
| 06-03 | Astellas Pharma Inc. - Special Call |
| Market Cap | 3,834B 23.93B 20.67B 19.05B 17.83B 33.41B 2,275B 33.93B 225B 87.69B 1,107B 89.82B 87.91B | P/E Ratio 2026 |
15.5x | P/E Ratio 2027 * | 11x |
|---|---|---|---|---|---|
| Enterprise Value | 4,262B 26.61B 22.98B 21.18B 19.82B 37.15B 2,529B 37.72B 250B 97.49B 1,231B 99.86B 97.73B | EV / Sales 2026 |
2.24x | EV / Sales 2027 * | 1.66x |
| Free-Float |
98.88% | Yield 2026 |
3.1% | Yield 2027 * | 3.76% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +1.57% | ||
| 1 week | -0.97% | ||
| Current month | -6.26% | ||
| 1 month | -9.97% | ||
| 3 months | -9.38% | ||
| 6 months | +4.14% | ||
| Current year | +2.25% |
| 1 week | 2,041 | 2,162.5 | |
| 1 month | 2,041 | 2,368 | |
| Current year | 2,041 | 2,717 | |
| 1 year | 1,343.5 | 2,717 | |
| 3 years | 1,243.5 | 2,717 | |
| 5 years | 1,243.5 | 2,717 | |
| 10 years | 1,243.5 | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 2023-02-09 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 2023-10-31 |
Tatjana Dragovic
CMP | Compliance Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 2023-02-09 |
Naoki Okamura
BRD | Director/Board Member | 63 | 2019-05-31 |
Takashi Tanaka
BRD | Director/Board Member | 69 | 2021-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.57% | -0.97% | +54.12% | -6.57% | 23.93B | ||
| -2.41% | +0.14% | +38.28% | +154.20% | 1,010B | ||
| +1.07% | +3.48% | +53.32% | +49.85% | 580B | ||
| +1.32% | +0.22% | +19.18% | +64.65% | 402B | ||
| +0.77% | 0.00% | +21.28% | +16.70% | 330B | ||
| +0.44% | +3.48% | +25.65% | +35.66% | 281B | ||
| -0.85% | -2.86% | +22.54% | +14.67% | 280B | ||
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | ||
| +0.32% | +1.61% | +20.32% | +60.01% | 192B | ||
| -0.22% | -2.76% | +14.19% | +60.09% | 156B | ||
| Average | +0.37% | +0.66% | +22.45% | +40.19% | 345.29B | |
| Weighted average by Cap. | -0.22% | +1.02% | +27.95% | +70.01% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 2,132B 13.31B 11.5B 10.59B 9.92B 18.58B 1,265B 18.87B 125B 48.77B 616B 49.95B 48.89B | 2,244B 14.01B 12.1B 11.15B 10.44B 19.56B 1,332B 19.86B 132B 51.33B 648B 52.57B 51.46B |
| Net income | 296B 1.85B 1.6B 1.47B 1.38B 2.58B 176B 2.62B 17.39B 6.78B 85.61B 6.95B 6.8B | 350B 2.18B 1.89B 1.74B 1.63B 3.05B 208B 3.1B 20.53B 8B 101B 8.2B 8.02B |
| Net Debt | 429B 2.68B 2.31B 2.13B 1.99B 3.74B 254B 3.79B 25.14B 9.8B 124B 10.04B 9.83B | -103B -641M -554M -511M -478M -896M -60.97B -909M -6.03B -2.35B -29.68B -2.41B -2.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 2,140.00 ¥ | +1.57% | 8,991,300 |
| 26-06-11 | 2,107.00 ¥ | -1.57% | 8,535,200 |
| 26-06-10 | 2,140.50 ¥ | -0.19% | 5,436,200 |
| 26-06-09 | 2,144.50 ¥ | -0.21% | 5,620,400 |
| 26-06-08 | 2,149.00 ¥ | -0.56% | 6,531,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions


















